Vytrus Biotech S.A. (VYT) — Capital Reinvestment Ratio
Vytrus Biotech S.A. (VYT) has a Capital Reinvestment Ratio of 2.19x as of December 2022, meaning it reinvests 2% of its operating cash flow (€225.55K) in capital expenditures (€494.16K). Check VYT intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Vytrus Biotech S.A. Capital Reinvestment Ratio (2021–2025)
This chart tracks Vytrus Biotech S.A.'s Capital Reinvestment Ratio across 5 annual periods. For the full cash flow conversion analysis, see Vytrus Biotech S.A. (VYT) cash flow conversion.
Annual Capital Reinvestment Ratio for Vytrus Biotech S.A. (2021–2025)
Year-by-year Capital Reinvestment Ratio for Vytrus Biotech S.A. from 2021 to 2025. See cash generation quality of Vytrus Biotech S.A. to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.69x | €3.90 Million | €2.68 Million | ▲ +5.2% |
| 2024 | 0.65x | €1.84 Million | €1.20 Million | ▼ -49.4% |
| 2023 | 1.29x | €904.39K | €1.17 Million | ▼ -41.1% |
| 2022 | 2.19x | €225.55K | €494.16K | ▲ +261.0% |
| 2021 | 0.61x | €447.92K | €271.82K | — |